Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients

NCT03290820 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

184

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

RADIATION: Radiotherapy
DRUG: Concurrent chemotherapy
DRUG: Aspirin

Sponsor

Sun Yat-sen University